KHK (Lys-His-Lys)
Research-Grade
KHK (Lys-His-Lys) is a copper-binding tripeptide composed of lysine-histidine-lysine, structurally related to the more widely studied GHK (Gly-His-Lys) copper peptide. Like GHK, KHK binds copper(II) ions through its histidine imidazole nitrogen and the amino-terminal nitrogen, forming a stable Cu2+ complex. The substitution of glycine with lysine at the N-terminal position alters the peptide's charge profile, copper-binding geometry, and cellular uptake characteristics, creating a distinct pharmacological entity with overlapping but non-identical biological activity compared to GHK-Cu. Copper peptides as a class promote tissue remodeling through several well-characterized mechanisms: stimulation of collagen I/III synthesis in dermal fibroblasts, upregulation of decorin and glycosaminoglycan production in the extracellular matrix, recruitment of mast cells to wound sites, promotion of angiogenesis through VEGF and FGF-2 expression, and anti-inflammatory activity via superoxide dismutase (SOD) mimetic action of the copper complex. KHK-Cu has been investigated primarily in dermatological and cosmeceutical contexts, where it has shown activity in promoting hair growth (via dermal papilla cell stimulation and Wnt/beta-catenin pathway modulation), accelerating wound closure, and reducing photoaging-associated collagen degradation. The additional positive charge from the N-terminal lysine residue may enhance electrostatic interaction with negatively charged glycosaminoglycans on cell surfaces, potentially improving cellular uptake in certain tissue contexts compared to GHK-Cu. However, head-to-head comparisons between KHK-Cu and GHK-Cu are limited in the published literature, and GHK-Cu remains far more extensively studied and clinically validated. KHK is primarily encountered in cosmeceutical formulations targeting hair loss and skin aging, often in combination with other copper peptides or growth factors. It has no regulatory approval as a drug in any jurisdiction.
Specifications
| Origin / Manufacturer | Synthetic |
| Form Factor | Topical serum / lyophilized powder |
Frequently Asked Questions
Sources & References
Every clinical claim on this page traces to a primary peer-reviewed source.
- 1Pickart L, Vasquez-Soltero JM, Margolina A.. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International. 2015. PMID:25861634
Reviewed by
Clinical Research Review Board
Pharmacology & Endocrinology Review
All clinical claims cross-checked against primary sources. Read our editorial policy →